Hrvatska -
hrvatski -
HALMED (Agencija za lijekove i medicinske proizvode)
metopirone 250 mg meke kapsule
hra pharma rare diseases, 200 avenue de paris, chatillon, francuska - metirapon - kapsula, meka - 250 mg - urbroj: jedna kapsula sadrži 250 mg metirapona
Hrvatska -
hrvatski -
Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane
defensor 3
pfizer croatia d.o.o., zagreb, hrvatska - inaktivirani virus bjesnoće, soj pv-paris, svr-289 - injekcijska suspenzija - pasa, mačaka, ovaca i goveda
Europska Unija -
hrvatski -
EMA (European Medicines Agency)
melatonin neurim
rad neurim pharmaceuticals eec sarl - melatonin - poremećaji uvođenja i održavanja spavanja - psycholeptics - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
Hrvatska -
hrvatski -
HALMED (Agencija za lijekove i medicinske proizvode)
resound essence, resound match, be by resound i resound x-plore
bontech research co d.o.o., split - slušno pomagalo
Hrvatska -
hrvatski -
HALMED (Agencija za lijekove i medicinske proizvode)
suction cannula by house, angl.luer-l
inel - medicinska tehnika d.o.o. orehovečki brijeg 2 10000 zagreb -
Europska Unija -
hrvatski -
EMA (European Medicines Agency)
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infekcije respiratornih sincicijskih virusa - cjepiva - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.
Europska Unija -
hrvatski -
EMA (European Medicines Agency)
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastična sredstva - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.